Position in BMRN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$57,220
+$730 QoQ
Shares Held
1,000
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#442
of 555 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALERUS FINANCIAL NA holds $9,984,044 across 7 Biotechnology names. BMRN ranks #3 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IMNM |
Immunome Inc.
|
383,421 | $8,124,690 | |
| 2 | LBRX |
Lb Pharmaceuticals Inc
|
54,891 | $1,781,487 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
This page
|
1,000 | $57,220 | |
| 4 | RNAC |
Cartesian Therapeutics, Inc.
|
1,000 | $10,420 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
18 | $8,941 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2 | $1,247 | |
| 7 | CVM |
Cel Sci Corp
|
38 | $39 |
All Filings in BMRN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $57,220 | 1,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $56,490 | 1,000 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $59,430 | 1,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $54,160 | 1,000 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $54,970 | 1,000 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||